Безопасен ли magnolol при беременности?

Безопасные альтернативы magnolol при беременности | VeriMom

Related ingredients

Frequently asked questions

Безопасен ли magnolol при беременности?

Animal and mechanistic data show magnolol can inhibit uterine smooth‑muscle contraction in rat uterus (in vitro) and maternal supplementation in mice altered placental morphology and angiogenesis; these constitute demonstrated reproductive/placental effects in animals (peer‑reviewed studies). No harmonised CLP or SCCS/CIR “safe as used” opinion was found to override those findings. Sources: rat uterine contraction study (PubMed) and a maternal mouse study. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/14504686/?utm_source=openai))

Безопасен ли magnolol при грудном вскармливании?

No data located showing effects on lactation, breastmilk levels, or infant outcomes. Given systemic distribution reported in pharmacokinetic reviews, a low but measurable exposure from absorbed maternal systemic exposure is plausible but not documented for topical cosmetic use. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8010308/?utm_source=openai))

Безопасен ли magnolol для кожи малыша?

No infant‑specific hazard or mechanism data found. Topical absorption for adults is not well quantified but magnolol is lipophilic and systemically bioavailable in animal PK studies; per the scoring rules, infant exposure score is increased by +1 relative to adults when measurable absorption is plausible, so baby exposure is rated moderate. No infant dermal safety studies located. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8010308/?utm_source=openai))

Как VeriMom оценивает magnolol?

VeriMom оценивает magnolol в 40/100 (средний риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы magnolol при беременности?

См. наш список безопасных альтернатив magnolol с аналогичной функцией и классификацией без известных рисков.